麻风患者家庭接触者中BCG诱导的免疫特征可区分保护与发病
研究在孟加拉国新诊断麻风患者的家庭接触者中分析全血固有与适应性免疫标志物,部分接触者曾接种BCG。结果显示BCG接种可在麻风杆菌暴露已诱导的免疫效应之上产生额外影响,并识别出可区分保护性免疫与易发病免疫的BCG诱导标志物。
要点
- BCG复种可降低麻风风险,但也可能诱发少菌型麻风。
- 在麻风患者家庭接触者中,BCG接种可额外改变免疫标志物。
- 已识别BCG诱导标志物可区分保护性与易发病免疫。
核心结论
- BCG接种在麻风杆菌暴露基础上对免疫标志物有额外效应,且BCG诱导标志物可区分保护与易发病免疫。
研究设计与样本
- 研究纳入孟加拉国新诊断麻风患者的家庭接触者(部分接受BCG接种),并设同地区无已知麻风接触者为对照,分析全血固有与适应性免疫标志物。
主要发现
- BCG接种对免疫标志物产生额外于麻风杆菌暴露的效应。
- 识别出BCG诱导的免疫标志物可在接触者中区分保护性免疫与易发病免疫。
临床怎么用
- 对麻风患者家庭接触者评估BCG接种时,可关注BCG诱导的免疫标志物以识别易发病个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leprosy is an infectious disease caused by Mycobacterium leprae leading to irreversible disabilities along with social exclusion. Leprosy is a spectral disease for which the clinical outcome after M. leprae infection is determined by host factors. The spectrum spans from anti-inflammatory T helper-2 (Th2) immunity concomitant with large numbers of bacteria as well as antibodies against M. leprae antigens in multibacillary (MB) leprosy, to paucibacillary (PB) leprosy characterised by strong pro-inflammatory, Th1 as well as Th17 immunity. Despite decades of availability of adequate antibiotic treatment, transmission of M. leprae is unabated. Since individuals with close and frequent contact with untreated leprosy patients are particularly at risk to develop the disease themselves, prophylactic strategies currently focus on household contacts of newly diagnosed patients. It has been shown that BCG (re)vaccination can reduce the risk of leprosy. However, BCG immunoprophylaxis in contacts of leprosy patients has also been reported to induce PB leprosy, indicating that BCG (re)vaccination may tip the balance between protective immunity and overactivation immunity causing skin/nerve tissue damage. In order to identify who is at risk of developing PB leprosy after BCG vaccination, amongst individuals who are chronically exposed to M. leprae, we analyzed innate and adaptive immune markers in whole blood of household contacts of newly diagnosed leprosy patients in Bangladesh, some of which received BCG vaccination. As controls, individuals from the same area without known contact with leprosy patients were similarly assessed. Our data show the added effect of BCG vaccination on immune markers on top of the effect already induced by M. leprae exposure. Moreover, we identified BCG-induced markers that differentiate between protective and disease prone immunity in those contacts.
引用
- van Hooij A, van den Eeden SJF, Khatun M, et al. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease. Vaccine. 2021. PMID: 34688497. doi:10.1016/j.vaccine.2021.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。